𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of the dopaminergic system in mood, motivation and cognition in Parkinson's disease: A double blind randomized placebo-controlled experimental challenge with pramipexole and methylphenidate

✍ Scribed by Rosa L. Drijgers; Frans R.J. Verhey; Gerrit Tissingh; Peter H.M.F. van Domburg; Pauline Aalten; Albert F.G. Leentjens


Book ID
119304582
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
191 KB
Volume
320
Category
Article
ISSN
0022-510X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A randomized, double-blind, placebo-cont
✍ Fabrizio Stocchi; Rupam Borgohain; Marco Onofrj; Anthony H.V. Schapira; Mohit Bh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

## Abstract Safinamide is an α‐aminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an add‐on to dopamine agonist (DA) therapy in early‐stage PD. In this 24‐week, double‐blind study, patients with early PD receiving a stable dose of a single DA were randomized to

The effects of rasagiline on cognitive d
✍ Hasmet A. Hanagasi; Hakan Gurvit; Pınar Unsalan; Hilal Horozoglu; Nese Tuncer; A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Abstract Cognitive impairment can occur at all stages of Parkinson's disease. Rasagiline is a selective monoamine oxidase type‐B inhibitor that enhances central dopaminergic transmission. Dopamine is thought to be involved in certain cognitive processes such as working memory. We assessed the ef

The impact of left prefrontal repetitive
✍ Endre Pal; Ferenc Nagy; Zsuzsanna Aschermann; Eva Balazs; Norbert Kovacs 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract Based on several open‐label and case studies, repetitive transcranial magnetic stimulation (rTMS) seems to have an antidepressive effect on patients with Parkinson's disease (PD). However, this hypothesis requires further confirmation. We conducted a randomized, double‐blind placebo‐con